Latest Integral Health Asset Management, LLC Stock Portfolio
$1.05Billion– No. of Holdings #69
Integral Health Asset Management, LLC Performance:
2024 Q2: 2.33%YTD: 14.57%2023: 13.73%
Performance for 2024 Q2 is 2.33%, and YTD is 14.57%, and 2023 is 13.73%.
About Integral Health Asset Management, LLC and 13F Hedge Fund Stock Holdings
Integral Health Asset Management, LLC is a hedge fund based in NEW YORK, NY. On 24-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $656.1 Millions. In it's latest 13F Holdings report, Integral Health Asset Management, LLC reported an equity portfolio of $1.1 Billions as of 30 Jun, 2024.
The top stock holdings of Integral Health Asset Management, LLC are INSM, THC, CYTK. The fund has invested 9.9% of it's portfolio in INSMED INC and 6.3% of portfolio in TENET HEALTHCARE CORP.
The fund managers got completely rid off WALGREENS BOOTS ALLIANCE INC (WBA), ABBVIE INC (ABBV) and CHARLES RIV LABS INTL INC (CRL) stocks. They significantly reduced their stock positions in INTUITIVE SURGICAL INC (ISRG), NEUROCRINE BIOSCIENCES INC (NBIX) and VIKING THERAPEUTICS INC (VKTX). Integral Health Asset Management, LLC opened new stock positions in BECTON DICKINSON & CO (BDX), EDWARDS LIFESCIENCES CORP (EW) and THERMO FISHER SCIENTIFIC INC (TMO). The fund showed a lot of confidence in some stocks as they added substantially to FATE THERAPEUTICS INC (FATE), CYTOKINETICS INC (CYTK) and KEROS THERAPEUTICS INC (KROS).
The top stock holdings of Integral Health Asset Management, LLC are INSM, THC, CYTK. The fund has invested 9.9% of it's portfolio in INSMED INC and 6.3% of portfolio in TENET HEALTHCARE CORP.
The fund managers got completely rid off WALGREENS BOOTS ALLIANCE INC (WBA), ABBVIE INC (ABBV) and CHARLES RIV LABS INTL INC (CRL) stocks. They significantly reduced their stock positions in INTUITIVE SURGICAL INC (ISRG), NEUROCRINE BIOSCIENCES INC (NBIX) and VIKING THERAPEUTICS INC (VKTX). Integral Health Asset Management, LLC opened new stock positions in BECTON DICKINSON & CO (BDX), EDWARDS LIFESCIENCES CORP (EW) and THERMO FISHER SCIENTIFIC INC (TMO). The fund showed a lot of confidence in some stocks as they added substantially to FATE THERAPEUTICS INC (FATE), CYTOKINETICS INC (CYTK) and KEROS THERAPEUTICS INC (KROS).
Integral Health Asset Management, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Integral Health Asset Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Integral Health Asset Management, LLC made a return of 2.33% in the last quarter. In trailing 12 months, it's portfolio return was 20.72%.
New Buys
| Ticker | $ Bought |
|---|---|
| becton dickinson & co | 17,528,200 |
| edwards lifesciences corp | 13,855,500 |
| thermo fisher scientific inc | 13,825,000 |
| quest diagnostics inc | 13,688,000 |
| amgen inc | 12,498,000 |
| ionis pharmaceuticals inc | 11,915,000 |
| mckesson corp | 11,680,800 |
| sanofi | 9,704,000 |
New stocks bought by Integral Health Asset Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| fate therapeutics inc | 325 |
| cytokinetics inc | 122 |
| keros therapeutics inc | 112 |
| inari med inc | 100 |
| apogee therapeutics inc | 100 |
| mereo biopharma group plc | 86.84 |
| blueprint medicines corp | 61.9 |
| elevance health inc | 60.00 |
Additions to existing portfolio by Integral Health Asset Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| intuitive surgical inc | -80.00 |
| neurocrine biosciences inc | -53.33 |
| viking therapeutics inc | -44.44 |
| bruker corp | -40.91 |
| merus n v | -39.39 |
| roivant sciences ltd | -33.33 |
| crispr therapeutics ag | -31.82 |
| revolution medicines inc | -22.62 |
Integral Health Asset Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| walgreens boots alliance inc | -28,197,000 |
| autolus therapeutics plc | -3,190,000 |
| avantor inc | -12,785,000 |
| macrogenics inc | -7,360,000 |
| alkermes plc | -6,767,500 |
| evolent health inc | -8,197,500 |
| 4d molecular therapeutics in | -7,965,000 |
| alpine immune sciences inc | -9,117,200 |
Integral Health Asset Management, LLC got rid off the above stocks
Sector Distribution
Integral Health Asset Management, LLC has about 93.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 93.9 |
| Others | 6.1 |
Market Cap. Distribution
Integral Health Asset Management, LLC has about 48.4% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 43.2 |
| MID-CAP | 33.6 |
| SMALL-CAP | 10.5 |
| UNALLOCATED | 6.8 |
| MEGA-CAP | 5.2 |
Stocks belong to which Index?
About 74.8% of the stocks held by Integral Health Asset Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 44.4 |
| S&P 500 | 30.4 |
| Others | 25.1 |
Integral Health Asset Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Integral Health Asset Management, LLC
Integral Health Asset Management, LLC has 69 stocks in it's portfolio. About 45% of the portfolio is in top 10 stocks. VKTX proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for Integral Health Asset Management, LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| A | agilent technologies inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ABBV | abbvie inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ABC | cencora inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ACLX | arcellx inc | 1.44 | 275,000 | 15,177,200 | added | 7.84 | ||
| AGLE | spyre therapeutics inc | 0.22 | 100,000 | 2,351,000 | unchanged | 0.00 | ||
| ALGN | align technology inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALKS | alkermes plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALNY | alnylam pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALPN | alpine immune sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMGN | amgen inc | 1.19 | 40,000 | 12,498,000 | new | |||
| APLS | apellis pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AUTL | autolus therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVTR | avantor inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXSM | axsome therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BDX | becton dickinson & co | 1.67 | 75,000 | 17,528,200 | new | |||
| BGNE | beigene ltd | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BPMC | blueprint medicines corp | 3.48 | 340,000 | 36,645,200 | added | 61.9 | ||
| BRKR | bruker corp | 0.79 | 130,000 | 8,295,300 | reduced | -40.91 | ||
| BSX | boston scientific corp | 4.76 | 650,000 | 50,056,500 | added | 8.33 | ||
| CABA | cabaletta bio inc | 0.30 | 425,000 | 3,179,000 | unchanged | 0.00 | ||